painkiller News
Most Popular painkiller Story
J&J's XR pain drug gets FDA nod
Johnson & Johnson's ($JNJ) stellar year for drug approvals continues. U.S. regulators have given a market nod to J&J unit Janssen's extended-release version of pain pill Nucynta. The company Read more...
Latest Headlines
- January 6, 2012
- August 26, 2011
- April 26, 2011
- April 20, 2011
- February 24, 2011
- August 14, 2009
- March 11, 2009
- December 23, 2008
- September 10, 2008
- April 22, 2008
- April 4, 2008
- November 30, 2007
- September 6, 2007
- August 6, 2007
- November 20, 2006
- September 28, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
